Southwest Oncology Group S0008: a phase III trial of high-dose interferon Alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with high-risk melanoma--an intergroup study of cancer and leukemia Group (Q34484199)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Southwest Oncology Group S0008: a phase III trial of high-dose interferon Alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with high-risk melanoma--an intergroup study of cancer and leukemia Group |
scientific article |
Statements
1 reference
Southwest Oncology Group S0008: a phase III trial of high-dose interferon Alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with high-risk melanoma--an intergroup study of cancer and leukemia Group (English)
1 reference
Megan Othus
1 reference
Vernon K Sondak
1 reference
Antoni Ribas
1 reference
Lawrence E Flaherty
1 reference
Michael B Atkins
1 reference
Ralph J Tuthill
1 reference
John A Thompson
1 reference
John T Vetto
1 reference
Frank G Haluska
1 reference
Alberto S Pappo
1 reference
Jeffrey A Sosman
1 reference
Bruce G Redman
1 reference
James Moon
1 reference
John M Kirkwood
1 reference
20 October 2014
1 reference
1 reference
32
1 reference
33
1 reference
3771-3778
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference